The researchers published a paper “Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States” on Feb. 6, 2021.
The study shows that:
1 The highly transmissible B.1.1.7 variant of SARS-CoV-2, which was first identified in the United Kingdom (U.K.), has gained a strong foothold across the world.
2 The RT-qPCR testing anomaly of S gene target failure (SGTF), first observed in the U.K., was a reliable proxy for B.1.1.7 detection.
3 While the fraction of B.1.1.7 among SGTF samples varied by state, detection of the variant increased at a logistic rate similar to those observed elsewhere, with a doubling rate of a little over a week and an increased transmission rate of 35-45%.
4 The U.S. is on a similar trajectory as other countries where B.1.1.7 rapidly became the dominant SARS-CoV-2 variant, requiring immediate and decisive action to minimize COVID-19 morbidity and mortality.
Read full paper:
Mike Pompeo: Ensuring a Transparent, Thorough Investigation of COVID-19’s Origin
The U.S. urges the WHO to press the government of China to address the following:
1 Illnesses at the Wuhan Institute of Virology (WIV):
2 WIV Research on “RaTG13” and “gain of function”
3 Secret WIV Links to Military Research
Secret military activity at the Wuhan Institute of Virology(WIV)
1 WIV has collaborated on publications 1and secret projects with China’s military.
2 WIV has engaged in classified research, including laboratory animal experiments, on behalf of the Chinese military since at least 2017.
3 The U.S. funded or collaborated on civilian research at WIV
The Obama administration ban on Gain of Function virus research
Dr. Li-Meng Yan claiming coronavirus cover-up tells ‘Bill Hemmer Reports’: ‘We don’t have much time’ on July 13, 2020
Dr. Li-Meng Yan, a virologist from Hong Kong, tells Fox News on July 10, 2020, in an exclusive interview about the early research she says she conducted into COVID-19, and why she believes that research was withheld from the world.
Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States https://www.medrxiv.org/content/10.1101/2021.02.06.21251159v1